The Defense Medical Research and Development Program (DMRDP) within the Office of the Assistant Secretary of Defense for Health Affairs is a core research program within DOD and is the focal point for the Defense Health Program’s research, development, test, and evaluation funds. On June 4th, DMRDP issued their Funding Opportunity Announcement (FOA) for the FY 14 “Military Infectious Diseases Clinical Trial Award” (MID-CTA).
DMRDP is exploring innovative approaches to support and advance the health of the military and their families. Their goal is to accelerate the transition of medical technologies and devices into deployed products to help set new standards of care for injury prevention, treatment, rehabilitation, and training systems that can be applied not only in theater, but in the clinical facilities within the Military Health System or in civilian healthcare facilities.
The term device in this FOA includes diagnostics such as in vitro and/or biomarkers. In vitro diagnostic products are those instruments and systems intended for use in diagnosing disease or other conditions including determining the state of health to cure, treat, or prevent disease
DOD is interested in projects focused on testing and translating investigational interventions or devices already proven in relevant animal models and moving into advanced clinical development. Funding for this award must support a clinical trial/testing and cannot be used for preclinical research studies.
There will be four awards with total program funding to be $11,400,000. The Funding Opportunity Number (W81XWH-14-DMRDP-MID-CTA) has a pre-application submission deadline of July 3, 2013. The application may be submitted starting August 2013 with the application submission deadline to be October 4, 2013.
Go to www.grants.gov/search/search.do?mode=VIEW&oppId=235939 for more information